Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Return to the main site

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > DMS Pharmaceutical loses its challenge to the VA

FDAnews Drug Daily Bulletin

April 10, 2012 | Vol. 9 No. 71

DMS Pharmaceutical loses its challenge to the VA

DMS Pharmaceutical Group lost a challenge to a decision by the United States Department of Veterans Affairs to exclude small businesses from a drug supply contract valued at as much as $32 billion.
China Daily

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue FDA Advisers Recommend Merck Insomnia Drug; Downplay Need for Additional Trials Senate Preps Track-and-Trace, Compounding Reform Bills for Floor Vote Ranbaxy Compliance Reforms Reflect FDA Manufacturing Recommendations

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.